Rentschler Biopharma is a leading global CDMO, focused exclusively on client projects. Thanks to our 50 years of proven scientific expertise in biotechnology, we count ourselves among the leaders in the industry. From our headquarters in Laupheim, Germany, and our sites in Milford, USA, and Stevenage, UK, we offer end-to-end solutions including biopharmaceutical and viral vector process development and cGMP manufacturing. Our Center of Excellence for advanced therapies is located in Stevenage, UK, the largest cell and gene therapy cluster in Europe. At Rentschler Biopharma’s Stevenage site for advanced therapies, we are dedicated to advancing viral vector products from development to cGMP manufacturing of high-quality gene therapies for our clients and their patients.
